Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Your skin deserves to catch up
CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031
Season with salt, pepper, and a pinch of turmeric
Consequently, the exendin-based compounds cause a higher degree of antibody formation, but it is questionable whether this is important for efficacy and safety (7, 8)
US$ 24.73
US$ 21.46
US$ 29.92
US$ 22.25
